Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

40% of Americans continue to put off medical care

Data: U.S. Census; Chart: Andrew Witherspoon

Roughly 40% of Americans have postponed getting medical care due to the coronavirus outbreak. That number has stayed around 40% in all 12 weeks of the Census Bureau's Household Pulse Survey.

Why it matters: Hospitals and doctors started rescheduling surgeries and other appointments as early as mid-May, and many patient volumes are mostly back to pre-pandemic numbers. But this data suggests there is still a major backlog of Americans who need care — a phenomenon that existed well before the pandemic.

Go deeper

Maria Arias
Nov 11, 2020 - Politics & Policy

White House urges Iowa to tighten restrictions as COVID-19 surges

Reynolds meets with Trump in May. Photo: Saul Loeb/AFP via Getty Images

Iowa is experiencing an "unyielding COVID spread," illustrated by swelling hospital admissions and ICU data, according to a Nov. 8 White House Coronavirus Task Force report obtained by the local ABC News affiliate.

Driving the news: Iowa Gov. Kim Reynolds, who has repeatedly said that strict rules were unnecessary and ineffective, on Tuesday issued limits on large gatherings and implemented a partial mask mandate for social settings and some businesses.

Go deeper (1 min. read)Arrow
Oriana Gonzalez
Nov 11, 2020 - Politics & Policy

Fauci: Working with Trump administration has "been very stressful"

Anthony Fauci. Photo: GRAEME JENNINGS/POOL/AFP via Getty Images

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said in a Wednesday interview that working alongside the Trump administration to combat the coronavirus in the U.S. has been "very stressful."

Why it matters: Although Fauci, who considers himself apolitical, is among the most trusted voices in the country on the coronavirus, he has faced attacks from Trump loyalists and the president himself, who recently called him a "disaster."

Go deeper (<1 min. read)Arrow
Shawna Chen
Nov 11, 2020 - Health

EU purchases 200 million doses of Pfizer's COVID-19 vaccine

Illustration: Sarah Grillo/Axios

The European Union struck a deal with Pfizer and BioNTech to buy at least 200 million doses of their coronavirus vaccine in the largest initial order to date, the companies announced Wednesday.

Driving the news: Pharmaceutical giant Pfizer announced Monday that its coronavirus vaccine trial was effective in preventing COVID-19 infections in 90% of previously uninfected people and did not produce any serious safety concerns.

Go deeper (<1 min. read)Arrow